Bristol Myers Squibb
New cell therapy facility at Leiden Bio Science Park
American pharmaceutical company Bristol Myers Squibb (BMS) established a new cell therapy facility in the Oegstgeest part of the Leiden Bio Science Park.
Location
Information
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
The location close to Schiphol Airport is one of the main reasons BMS is located in LBSP Oegstgeest, an easy gateway to the rest of the world.
Completed
-
2021-2024
Run time
-
Life, Science & Health
Type
-
Gemeente Leiden Universiteit Leiden
Landowner
-
19.000 m2
Surface area
- Credits Architect: KuiperCompagnons
- Roadworks Roadworks may affect traffic in the local area. For more information, please press the red button ‘All roadworks’.
Comparable projects
-
Completed Rijnlandroute - Comol 5The Rijnland Route is a new road connection from Katwijk, via the A44 to the A4 in Leiden.... -
Completed Plus Ultra LeidenA new multi-tenant building by Kadans Science Partner at the entrance to the Bio Science P... -
Planned Pesthuis ComplexA food hall, work spaces, a hostel, a short-stay hotel, restaurants, art and culture. The ...